# A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer

> **NCT00383266** · PHASE2 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 9 (actual)

## Conditions studied

- Esophageal Neoplasms

## Interventions

- **DRUG:** Pemetrexed
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT00383266
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-10
- **Primary completion:** 2009-11
- **Final completion:** 2010-06
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Low accrual
- **Last updated:** 2016-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00383266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00383266, "A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00383266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*